GARCIA PETER S 4
4 · ALX ONCOLOGY HOLDINGS INC · Filed Jan 3, 2024
Insider Transaction Report
Form 4
GARCIA PETER S
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-12-29$15.04/sh−1,893$28,471→ 85,348 total
Footnotes (2)
- [F1]The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
- [F2]Includes 503 shares acquired under the Issuer's employee stock purchase plan on December 29, 2023.